Tomomasa Takamiya Selected Research

Tachycardia (Tachyarrhythmias)

1/2021	Impact of diagnosis-to-ablation time on non-pulmonary vein triggers and ablation outcomes in persistent atrial fibrillation.
12/2020	One-year outcomes after pulmonary vein isolation plus posterior wall isolation and additional non-pulmonary vein trigger ablation for persistent atrial fibrillation with or without contact force sensing: a propensity score-matched comparison.
12/2020	Cryoballoon versus radiofrequency ablation for paroxysmal atrial fibrillation in hemodialysis patients.
4/2019	Pulmonary vein isolation plus left atrial posterior wall isolation and additional nonpulmonary vein trigger ablation using high-dose isoproterenol for long-standing persistent atrial fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomomasa Takamiya Research Topics

Disease

7	Atrial Fibrillation 01/2021 - 12/2016
4	Tachycardia (Tachyarrhythmias) 01/2021 - 04/2019
3	Ventricular Tachycardia 03/2024 - 07/2019
1	Cicatrix (Scar) 12/2023
1	Pericardial Effusion 12/2023
1	Heart Failure 01/2021
1	Infarction (Infarctions) 07/2019
1	Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome) 12/2016
1	Hypertension (High Blood Pressure) 12/2016

Drug/Important Bio-Agent (IBA)

3	Anti-Arrhythmia AgentsIBA 12/2020 - 04/2019
1	SteamIBA 12/2023
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 04/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2016

Therapy/Procedure

7	Catheter Ablation 03/2024 - 04/2019
2	Catheters 12/2023 - 12/2020
2	Radiofrequency Ablation 12/2020 - 01/2019
1	Renal Dialysis (Hemodialysis) 12/2020